Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: Results of the multicentre HITIT study;Türkiye'de hastane izolatι gram-negatif bakterilerde yeni beta-laktam antibiyotiklere direnç ve GSBL tipleri: Çok merkezli Hṫi̇t sürveyansιnιn sonuçlarι

Mikrobiyoloji Bulteni

Volumn 42, Issue 4, 2008, Pages 537-544

  Gür, Deniz ^a   Gülay, Zeynep ^b   Arikan Akan, Özay ^c   Aktaş, Zerrin ^d   Bal Kayacan, Çiǧdem ^d   Çakici, Özlem ^e   Eraç, Bayri ^b   Gültekin, Meral ^f   Öǧünç, Dilara ^f   Söyletir, Güner ^e   Ünal, Nilgün ^g   Uysal, Sevil ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e MARMARA UNIVERSITY   (Turkey)

^f AKDENIZ UNIVERSITY   (Turkey)

^g KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Antimicrobial resistance; Beta lactamase inhibitor; CTX M; Extended spectrum beta lactamase; Gram negative bacteria

Indexed keywords

EID: 55949092336     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Paterson DL, Ko WC, Gottberg AV, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum Β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001; 39: 2206-12.
2. Stürenburg E, Mack D. Extended-spectrum Β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47: 273-95.
3. Paterson DL, Bonomo RA. Extended-spectrum Β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Seventeenth Informational Supplement. CLSI Document M100-S17. 2007. Clinical and Laboratory Standards Institute, Wayne, Pa.
5. Rodríguez-Baño J, Navarro MID, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089-94.
6. Kim J, Lim Y, Jeong YS, Seol Sy. Occurence of CTX-M-3, CTX-M-15, CTX-M-14 and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005; 49: 1572-5.
7. Jeong SH, Bae IK, Kwon SB, et al. Dissemination of transferable CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli in Korea. J Appl Microbiol 2005; 98: 921-7.
8. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
9. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella prieumonioe. Antimicrob Agents Chemother 2004; 48: 15-22.
10. Yildirim I, Ceyhan M, Gür D, Mugnaioli C, Rossolini GM. First detection of VIM-1 type metallo-beta-lactamase in a multidrug-resistant Klebsiello prieumonioe clinical isolate from Turkey also producing the CTX-M-15 extended-spectrum beta-lactamase. J Chemother 2007; 19: 467-8.
11. Eraksoy H, Basustaoglu A, Korten V, et al. Susceptibility of bacterial isolates from Turkey-A report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program. J Chemother 2007; 19: 650-7.
12. Livermore D, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165-74.
13. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
14. Way Z, Biçmen M, Atay T. Cefotaximase-M type beta-lactamase production in Escherichio coli isolated at a university hospital in Turkey. Microbiologica Balkanica 2003, Istanbul. Abstract no: 1564.
15. Ayhan Y, Gülay Z, Biçmen M, Gülfidan G, Meşe T, Inan S. Outbreak due to Salmonella enterica serovar Typhimurium producing SHV-12 and CTX-M-3 extended spectrum beta-lactamases (ESBLs) at a children's hospital. Microbiologica Balkanica 2003, Istanbul. Abstract no: 356.
16. Açikgöz ZC, Gülay Z, Biçmen M, Göçer S, Gamberzade S. CTX-M-3 extended-spectrum beta-lactamase in a Shigello sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2003; 35: 503-5.
17. Aktaş Z, Gönüllü N, Schneider I, Bal Ç, Bauernfeind A. Detection of CTX-M-15 type extended-spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient. Mikrobiyol Bul 2005; 39: 421-9.
18. Lartigue MF, Poirel L, Héritier C, Tolun V, Nordmann P. First description of CTX-M-15 producing Klebsiella pneumoniae in Turkey. J Antimicrob Chemother 2003; 52: 315-6.
19. Paterson DL, Hujer KM, Hujer MA, et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-Type β-lactamases. Antimicrob Agents Chemother 2003; 47: 3554-60.